Navitor Pharmaceuticals, Inc., is a biopharmaceutical company developing novel medicines by targeting cellular nutrient signaling pathways. The company’s proprietary drug discovery platform targets mTORC1, which responds to and integrates the cell’s response to nutrient availability and plays a key role in protein synthesis and cellular growth. Navitor’s therapeutics are designed to selectively modulate the cellular signals that are aberrant in disease processes caused by the dysregulation of mTORC1 activity to address a wide range of diseases, including metabolic, CNS, autoimmune and musculoskeletal diseases, as well as several rare disorders. The company is backed by leading financial and corporate investors, including Polaris Partners, Atlas Venture, J&J Innovation - JJDC, SR One, Brace Pharma Capital, Remeditex ventures, Sanofi Ventures and The Longevity Fund.
Company Details
- Employees
- 10
- Founded
- -
- Address
- 1030 Massachusetts Ave, Suite 410, Cambridge,ma 02139,united States
- Phone
- 781-538-6113
- pa****@****rma.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- navitorpharma.com
- Keywords
- jobs.
- HQ
- Cambridge, MA
Navitor Pharmaceuticals Questions
Navitor Pharmaceuticals's helpline number is 781-538-6113
Navitor Pharmaceuticals's website is navitorpharma.com
Navitor Pharmaceuticals's LinkedIn profile is https://www.linkedin.com/company/navitor-pharmaceuticals
Navitor Pharmaceuticals has
10 employees.
View email and phone details for 10
employees at Navitor Pharmaceuticals.
Navitor Pharmaceuticals's industry is
Biotechnology Research
Navitor Pharmaceuticals's top competitors are
Alnylam Pharmaceuticals,
Scpharmaceuticals,
Matchpoint Therapeutics,
Otsuka Pharmaceutical Companies (U.s.),
Biogen,
Phathom Pharmaceuticals,
Arkuda Therapeutics,
Vertex Pharmaceuticals,
Agios Pharmaceuticals,
Supernus Pharmaceuticals, Inc..
Navitor Pharmaceuticals's support email address is partnering@navitorpharma.com
Navitor Pharmaceuticals's categories are Biotechnology Research
Navitor Pharmaceuticals's founding year is 2010
